Improving SLE Management: Bridging Communication Gap in Patients and Clinicians
The following is a summary of “Communication GAP between patients and clinicians and the importance of patient reported outcomes in Systemic Lupus Erythematosus,” published in the March 2024 issue of...
View ArticleAnalyzing Ultrasound-guided Nerve Blocks in the Practice of Emergency Medicine
The following is a summary of “Ultrasound-guided nerve blocks in emergency medicine practice: 2022 updates,” published in the April 2024 issue of Emergency Medicine by Goldsmith, et al. For a study,...
View ArticleALT-70 Prediction Model and Thermal Imaging Validation to Differentiate...
The following is a summary of “Validation of Thermal Imaging and the ALT-70 Prediction Model to Differentiate Cellulitis From Pseudocellulitis,” published in the March 2024 issue of Dermatology by...
View ArticleATP2A2 Gene: Analyzing Persistent Cutaneous Lesions of DD and Second-Hit...
The following is a summary of “Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene,” published in the March 2024 issue of Dermatology by Atzmony, et al. Darier...
View ArticleAnalyzing the Incident CKD Risk, Gut Microbe Metabolite TMAO, & Kidney...
The following is a summary of “Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline,” published in the May 2024 issue of Nephrology by Wang et al. Trimethylamine...
View ArticleLarge language models (LLMs) demonstrated higher error rates compared to...
1. A comparative evaluation tested five publicly available LLMs on 2044 oncology questions, covering comprehensive topics in the field. The responses were compared to a human benchmark. 2. Only one of...
View ArticleEnhancing Surgical Precision: 3D Printing and Custom Metal Plates for...
The following is a summary of “Surgical treatment outcomes of the acetabular posterior wall and posterior column fractures using 3D printing technology and individualized custom-made metal plates: a...
View ArticleImpact of Oncogenic Drivers and Immune Landscapes in YA with NSCLC
The following is a summary of “Young adults (YA) with non-small cell lung cancer (NSCLC): Snapshot of the oncogenic drivers and immune landscapes,” published in 2024 ASCO Annual Meeting under issue of...
View ArticleAnxiety Screening Supported by Hopkins Symptom Checklist-10 for Patients With...
The Hopkins Symptom Check-10 (HSCL-10) shows potential in the diagnosis of psychiatric disorders, including anxiety and depression, in patients with SUD. Although comorbid psychiatric disorders are...
View ArticleExamining Care Quality in Early-Stage Resected NSCLC: EGFR Testing and...
The following is a summary of “Assessing quality of care in early-stage resected stage non-small cell lung cancer (NSCLC): An evaluation of epidermal growth factor receptor (EGFR) testing and adjuvant...
View ArticleExploring Atezolizumab Combination Therapy for NSCLC: J-TAIL-2 Study
The following is a summary of “J-TAIL-2: A prospective observational study of atezolizumab (atezo) combination therapy in patients (pts) with non-small cell lung cancer (NSCLC) in Japan,” published in...
View ArticleAnalyzing Tandem Transplant Outcomes in Patients with NDMM: Real-world Insights
The following is a summary of “Real-world outcomes (RWO) with tandem transplantation in patients (pts) with newly diagnosed multiple myeloma (NDMM),” published in the 2024 ASCO Annual Meeting under the...
View Article10 Predictions From the Beginning of 2024: Are They Still True?
In the Physician’s Weekly (PW) podcast‘s first episode of 2024, host Rachel Giles, MD, and PW editorial board member Alex McDonald, MD, discussed their perspectives on anticipated medical breakthroughs...
View ArticleInsights into Electronic OAM Adherence in Patients with MM: Patterns and...
The following is a summary of “Patterns and predictors of electronically measured oral anticancer medication (OAM) adherence among patients with multiple myeloma (MM).,” published in the 2024 ASCO...
View ArticleAnalysis of Palliative Care Accessibility in Patients with Multiple Myeloma
The following is a summary of “Access to palliative care in patients with multiple myeloma in the USA: A National Cancer Database (NCDB) analysis of years 2004-2020.,” published in the 2024 ASCO Annual...
View ArticleExamining the Link Between Treatment Patterns and Financial Fragility in...
The following is a summary of “Association between financial fragility and treatment patterns in multiple myeloma.,” published in the 2024 ASCO Annual Meeting under the issue of Oncology by Su et al....
View ArticleExamining the Link Between Social Determinants of Time and Health to...
The following is a summary of “Association between social determinants of health and time to treatment for newly diagnosed multiple myeloma,” published in the 2024 ASCO Annual Meeting under the issue...
View ArticleSurvival Outcomes in Early-Stage NSCLC With Rare Mutations
Targeted therapies, specifically for mutations like EGFR and ALK, significantly evolved the treatment landscape for non-small cell lung cancer (NSCLC), according to research presented at the 2024 ASCO...
View ArticleExamining Mortality in Patients With Multiple Myeloma and the Role of...
According to research presented at the 2024 ASCO Annual Meeting, patients with multiple myeloma (MM) are highly immunocompromised, either due to the disease’s nature, characterized by...
View ArticleFixed-Duration Regimen Substantially Benefits PFS in Patients With CLL/SLL
Researchers at the 2024 ASCO Annual Meeting presented long-term survival outcomes of patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) who were treated with...
View Article